Theodore Halkias - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Business Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Sep 2021
Net transactions value
-$4,536,313
Form type
4
Filing time
15 Sep 2021, 17:19:18 UTC
Next filing
28 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $58,553 +58,553 +1078% $1.00* 63,987 14 Sep 2021 Direct F1
transaction AGL Common Stock Sale $1,696,866 -58,553 -92% $28.98 5,434 14 Sep 2021 Direct F1
transaction AGL Common Stock Sale $2,898,000 -100,000 -100% $28.98 0 14 Sep 2021 By trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -58,553 -3.3% $0.000000 1,741,447 14 Sep 2021 Common Stock 58,553 $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These shares of common stock were held in the Halkias Irrevocable Trust.
F3 These options were granted on April 27, 2017, and fully vested on May 15, 2017.